Form D · Biotechnology
Rudhira Biosciences, Inc.
Cary, NC · CIK 0002083820
Offering snapshot reported Aug 28, 2025 · SEC filing
- Reported sold
- $80K Offering amount: $500K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Aug 18, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 28, 2025 | Initial | $80,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-556086
Source: Form D, filed Aug 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vijaya Kumar Singamsetty | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1146 Kingston Grove Drive
Cary, NC, 27519
Cary, NC, 27519